Markel Group’s stock exhibits a beta of 0.80, indicating its share price moves roughly 20% less than the S&P 500, underscoring its defensive profile in turbulent markets. According to MarketBeat.com, analyst sentiment skews positive: of the five published ratings, there are zero sell recommendations, two holds, two buys and one strong buy, yielding an aggregate rating score of 2.80 on a 1–5 scale. This consensus positions MKL ahead of many peers in the specialty insurance and investment-laden conglomerate space.

For the trailing twelve months, Markel Group generated $16.62 billion in gross revenue and reported net income of $2.75 billion, translating to diluted earnings per share of $159.74. The shares trade at a price-to-sales ratio of 1.56 and a price-to-earnings ratio of 12.87. Despite a consensus price target of $2,025.00 implying a modest 1.5% downside from current levels, analysts emphasize the strength of MKL’s underwriting combined with its growing investment portfolio as key drivers behind its solid revenue and profit growth profile.

Markel Group delivers robust profitability metrics, with net margins of 12.99%, a return on equity of 7.76% and a return on assets of 2.03%. Institutional investors hold 77.1% of its outstanding shares, reflecting broad support from pension funds, endowments and asset managers. Insider ownership stands at a modest 1.7%, signaling limited insider selling pressure and alignment of executive interests with long-term shareholder value creation.